Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Antimicrobial properties found in scorpion venom
The study highlights the potential for other healing compounds to be identified in the toxins of scorpions, snakes, snails and other creatures. (Stock photo)
Compounds kill staph and drug-resistant TB bacteria - study

Scientists have discovered two healing compounds in scorpion venom that can kill staphylococcus and drug-resistant TB bacteria.

The scorpion, Diplocentrus melici (not pictured), is native to eastern Mexico and can only be found in the rainy season - it is buried during the winter and dry seasons. When researchers milked its venom, they noticed they it changed from clear to brownish in colour when exposed to the air.

Two chemical compounds were found to be responsible for the colour change, one of which turned red when exposed to air, the other blue. The compounds are two previously unknown benzoquinones, a class of ring-like molecules known to have antimicrobial properties.

Through much trial and error, the team - which comprised researchers from Stanford and Mexico - managed to synthesise the compounds. The red benzoquinone was particularly effective at killing staphylococcus bacteria, while the blue one was lethal to both normal and multi-drug-resistant strains of TB-causing bacteria.

Researchers said being able to synthesise the venom is highly important, as the amount of venom components that can be obtained from animals is extremely low.

The team are planning to work together in determining why the compounds are present in the venom and whether they can be transformed into drugs. Their findings have been published in the journal Proceedings of the National Academy of Sciences.

Become a member or log in to add this story to your CPD history

Submissions open for BSAVA Clinical Research Abstracts 2026

News Story 1
 The BSAVA has opened submissions for the BSAVA Clinical Research Abstracts 2026.

It is an opportunity for applicants to present new research on any veterinary subject, such as the preliminary results of a study, discussion of a new technique or a description of an interesting case.

They must be based on high-quality clinical research conducted in industry, practice or academia, and summarised in 250 words.

Applications are welcome from vets, vet nurses, practice managers, and students.

Submissions are open until 6 March 2026. 

Click here for more...
News Shorts
Survey seeks ruminant sector views on antimicrobial stewardship

A new survey is seeking views of people working in the UK ruminant sector on how to tackle the challenge of demonstrating responsible antibiotic stewardship.

Forming part of a wider, collaborative initiative, the results will help identify the types of data available so that challenges with data collection can be better understood and addressed.

Anyone working in the UK farming sector, including vets and farmers,is encouraged to complete the survey, which is available at app.onlinesurveys.jisc.ac.uk